EGFR and non-small cell lung carcinoma: Regarding the correlation between mutation profile and BM prognosis, Shin et al. demonstrated that patients with EGFR-mutant NSCLC underwent salvage therapy after stereotactic radiosurgery more often than patients with EGFR wild-type tumors (p = 0.04) [30].